Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
Open Access
- 10 February 2022
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 12 (2) , 109
Abstract
Immunotherapy is a promising modality of treatment for cancer. Immunotherapy is comprised of systemic and local treatments that induce an immune response, allowing the body to fight back against cancer. Systemic treatments such as cancer vaccines harness antigen presenting cells (APCs) to activate T cells with tumor-associated antigens. Small molecule inhibitors can be employed to inhibit immune checkpoints, disrupting tumor immunosuppression and immune evasion. Despite the current efficacy of immunotherapy, improvements to delivery can be made. Nanomaterials such as mesoporous silica can facilitate the advancement of immunotherapy. Mesoporous silica has high porosity, decent biocompatibility, and simple surface functionalization. Mesoporous silica can be utilized as a versatile carrier of various immunotherapeutic agents. This review gives an introduction on mesoporous silica as a nanomaterial, briefly covering synthesis and biocompatibility, and then an overview of the recent progress made in the application of mesoporous silica to cancer immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (81872368, 81803376)
- Shenzhen Science and Technology Innovation Commission Key Projects of Fundamental Research and Program for Building Shenzhen City and State Key Laboratories (JCYJ20180508152130899)
- Shenzhen Development and Reform Commission Subject Construction Project ([2017]1432)
- Science and Technology Innovation Commission of Shenzhen (RCBS20200714114910141, JCYJ20210324132816039)
- Harbin Institute of Technology (HA45001108, HA11409049)
This publication has 147 references indexed in Scilit:
- Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silicaInternational Journal of Nanomedicine, 2013
- Mesoporous Silica Nanoparticles Act as a Self‐Adjuvant for Ovalbumin Model Antigen in MiceSmall, 2013
- Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic CellsFrontiers in Immunology, 2013
- Mesoporous silica nanoparticles in biomedical applicationsChemical Society Reviews, 2012
- Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic ActivityACS Nano, 2011
- Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other TumorsCancer Biotherapy and Radiopharmaceuticals, 2010
- Facile Synthesis of Monodisperse Spherical MCM-48 Mesoporous Silica Nanoparticles with Controlled Particle SizeChemistry of Materials, 2010
- Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery SystemsPharmaceuticals, 2010
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearanceAdvanced Drug Delivery Reviews, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007